Regulatory services in Israel

Regulatory lifecycle management in Israel

Medicalix helps maintain registered product portfolios in Israel through renewals, variations, leaflet and labeling updates, and coordination of regulatory changes. The aim is a clear view of each product's status, responsibilities and next required action.

Discuss this service

Who this service is for

For companies with an existing Israeli portfolio, teams managing manufacturing or product-information changes, and businesses transferring work between providers. Lifecycle support can be ongoing or limited to a defined group of changes.

Deliverables we can agree with you

  • A portfolio status map with registration records, deadlines and open regulatory items.
  • An assessment of planned changes and the information needed to determine the local submission approach.
  • Coordination of renewal and variation documentation with manufacturers and global teams.
  • Alignment checks between approved information, proposed leaflets and labeling, within the agreed scope.

How the work progresses

  1. Establish the baseline

    Collect the current registration position, available approved documents and outstanding commitments for each product.

  2. Prioritize work

    Map deadlines and proposed changes, identify dependencies and agree who will supply and approve each document.

  3. Track through closure

    Coordinate submissions and responses, update the status record and hand over the resulting documents.

What to prepare for an initial conversation

Prepare a portfolio list with registration identifiers, expiry dates, pending submissions, planned changes and the latest approved product information. If records are incomplete, a focused gap review can be the first work package.

Service scope

Medicine renewals and amendments have distinct Ministry of Health procedures. Device maintenance follows the applicable AMAR guidance. The submission route and timing should be checked for the specific change rather than assumed from a global change category.

Common questions

Can Medicalix take over an existing portfolio?

Yes, subject to an agreed handover and scope. The first step is to establish the current status, available records, responsibilities and any urgent open items.

Does a global labeling change automatically apply in Israel?

The local implications need review. The approved Israeli information, the reason for the change and applicable requirements should be assessed before local implementation.

Can support be limited to renewals or a backlog?

Yes. A defined project can focus on renewals, a set of variations, leaflet updates or a backlog, with deliverables and completion criteria agreed in advance.

Official sources

Consulted when preparing this page on 14 October 2026. Check the applicable current guidance before acting.

Talk to AvnerWhatsApp